Molecular targeted therapy: Treating cancer with specificity

Area of Science:

• Oncology
• Pharmacology
• Biochemistry

Background:

• Cancer involves uncontrolled cell growth, progression, and metastasis.
• Molecular targeted therapies represent a paradigm shift in cancer treatment.
• These therapies target specific molecules crucial for cancer cell survival and proliferation.

Purpose of the Study:

• To provide an updated overview of molecular targeted therapies in cancer treatment.
• To elucidate the fundamental principles and mechanisms of action of these therapies.
• To discuss the advantages and limitations associated with molecular targeted therapy.

Main Methods:

• Literature review of peer-reviewed articles and clinical trial data.
• Analysis of FDA-approved molecular targeted therapies.
• Synthesis of information on therapeutic targets, drug classes, and clinical outcomes.

Main Results:

• Molecular targeted therapies have shown significant success across diverse cancer types, including breast, leukemia, colorectal, lung, and ovarian cancers.
• Approved therapies demonstrate efficacy by interfering with specific molecular pathways essential for cancer.
• The review categorizes therapies based on their molecular targets and mechanisms.

Conclusions:

• Molecular targeted therapies are a cornerstone of modern cancer treatment, offering improved efficacy and reduced toxicity compared to traditional chemotherapy.
• Understanding the specific molecular alterations in a patient's tumor is crucial for selecting the most effective targeted therapy.
• Continued research is essential to overcome resistance mechanisms and expand the application of molecular targeted therapies.